Neuropeptide receptor positive allosteric modulation in epilepsy: Galanin modulation revealed

Por Hoyer, Daniel
Publicado em 2010

Reviewer comments on Reflections on drug research by Sir James Black

Por Hoyer, Daniel
Publicado em 2010

Identification and pharmacological characterization of somatostatin receptors in rat lung

Por Schloos, Jürgen, Raulf, Friedrich, Hoyer, Daniel, Bruns, Christian
Publicado em 1997

Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in rats

Por Semenova, Svetlana, Hoyer, Daniel, Geyer, Mark A., Markou, Athina
Publicado em 2010

The role of α(2)-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat

Por Kalkman, Hans O, Neumann, Vroni, Hoyer, Daniel, Tricklebank, Mark D
Publicado em 1998

Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs

Por Cervia, Davide, Nunn, Caroline, Fehlmann, Dominique, Langenegger, Daniel, Schuepbach, Edi, Hoyer, Daniel
Publicado em 2003

Comparison of functional profiles at human recombinant somatostatin sst(2) receptor: simultaneous determination of intracellular Ca(2+) and luciferase expression in CHO-K1 cells

Por Nunn, Caroline, Cervia, Davide, Langenegger, Daniel, Tenaillon, Laurent, Bouhelal, Rochdi, Hoyer, Daniel
Publicado em 2004

Finite element analysis of adhesive endo-crowns of molars at different height levels of buccally applied load

Por Hasan, Istabrak, Frentzen, Matthias, Utz, Karl-Heinz, Hoyer, Daniel, Langenbach, Alexander, Bourauel, Christoph
Publicado em 2012

The Rostral Anterior Cingulate Cortex Modulates the Efficiency of Amygdala-Dependent Fear Learning

Por Bissière, Stephanie, Plachta, Nicolas, Hoyer, Daniel, Olpe, Hans-Rudolf, Grace, Anthony A., Cryan, John F.
Publicado em 2007

Applications of a Rat Multiple Tissue Gene Expression Data Set

Por Walker, John R., Su, Andrew I., Self, David W., Hogenesch, John B., Lapp, Hilmar, Maier, Rainer, Hoyer, Daniel, Bilbe, Graeme
Publicado em 2004

Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference

Por Thakker, Deepak R., Natt, Francois, Hüsken, Dieter, Maier, Rainer, Müller, Matthias, van der Putten, Herman, Hoyer, Daniel, Cryan, John F.
Publicado em 2004

The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors

Por Mang, Géraldine M., Dürst, Thomas, Bürki, Hugo, Imobersteg, Stefan, Abramowski, Dorothee, Schuepbach, Edi, Hoyer, Daniel, Fendt, Markus, Gee, Christine E.
Publicado em 2012

Novel, Potent and Radio-Iodinatable Somatostatin Receptor 1 (sst(1)) Selective Analogues

Por Erchegyi, Judit, Cescato, Renzo, Grace, Christy Rani R., Waser, Beatrice, Piccand, Véronique, Hoyer, Daniel, Riek, Roland, Rivier, Jean E., Reubi, Jean Claude
Publicado em 2009

Hippocampal 5‐HT(7) receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated‐neurotransmission in vitro and in vivo

Por Andreetta, Filippo, Carboni, Lucia, Grafton, Gillian, Jeggo, Ross, Whyment, Andrew D, van den Top, Marco, Hoyer, Daniel, Spanswick, David, Barnes, Nicholas M
Publicado no Br J Pharmacol (2016)

Distinct effects of IPSU and suvorexant on mouse sleep architecture

Por Hoyer, Daniel, Dürst, Thomas, Fendt, Markus, Jacobson, Laura H., Betschart, Claudia, Hintermann, Samuel, Behnke, Dirk, Cotesta, Simona, Laue, Grit, Ofner, Silvio, Legangneux, Eric, Gee, Christine E.
Publicado em 2013

The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of...

Por Frentzel Stefan, Hoyer Daniel, Betschart Claudia, Bleckmann Dorothee, Kama Jibrin A, Dorsey Kate, Chopra Vanita, Connor Teal, Fox Jonathan H, DiFiglia Marian, Paganetti Paolo, Hersch Steven M
Publicado em 2010-06-01

The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of...

Por Fox, Jonathan H, Connor, Teal, Chopra, Vanita, Dorsey, Kate, Kama, Jibrin A, Bleckmann, Dorothee, Betschart, Claudia, Hoyer, Daniel, Frentzel, Stefan, DiFiglia, Marian, Paganetti, Paolo, Hersch, Steven M
Publicado em 2010

AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation

Por Feuerbach, Dominik, Pezous, Nicole, Weiss, Markus, Shakeri-Nejad, Kasra, Lingenhoehl, Kurt, Hoyer, Daniel, Hurth, Konstanze, Bilbe, Graeme, Pryce, Christopher R, McAllister, Kevin, Chaperon, Frederique, Kucher, Klaus, Johns, Donald, Blaettler, Thomas, Lopez Lopez, Cristina
Publicado no Br J Pharmacol (2015)

Kinetic properties of “dual” orexin receptor antagonists at OX(1)R and OX(2)R orexin receptors

Por Callander, Gabrielle E., Olorunda, Morenike, Monna, Dominique, Schuepbach, Edi, Langenegger, Daniel, Betschart, Claudia, Hintermann, Samuel, Behnke, Dirk, Cotesta, Simona, Fendt, Markus, Laue, Grit, Ofner, Silvio, Briard, Emmanuelle, Gee, Christine E., Jacobson, Laura H., Hoyer, Daniel
Publicado em 2013

Updating the guidelines for data transparency in the British Journal of Pharmacology – data sharing and the use of scatter plots instead of bar charts

Por George, Christopher H, Stanford, S Clare, Alexander, Steve, Cirino, Giuseppe, Docherty, James R, Giembycz, Mark A, Hoyer, Daniel, Insel, Paul A, Izzo, Angelo A, Ji, Yong, MacEwan, David J, Sobey, Christopher G, Wonnacott, Sue, Ahluwalia, Amrita
Publicado no Br J Pharmacol (2017)